|
1.
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Bray FI and Weiderpass E: Lung cancer
mortality trends in 36 European countries: secular trends and birth
cohort patterns by sex and region 1970–2007. Int J Cancer.
126:1454–1466. 2010.PubMed/NCBI
|
|
3.
|
Lam WK, White NW and Chan-Yeung MM: Lung
cancer epidemiology and risk factors in Asia and Africa. Int J
Tuberc Lung Dis. 8:1045–1057. 2004.PubMed/NCBI
|
|
4.
|
Youlden DR, Cramb SM and Baade PD: The
International Epidemiology of Lung Cancer: geographical
distribution and secular trends. J Thorac Oncol. 3:819–831. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Soon YY, Stockler MR, Askie LM, et al:
Duration of chemotherapy for advanced non-small cell lung cancer: a
systematic review and meta-analysis of randomized trials. J Clin
Oncol. 27:3277–3283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Lee JH, Miele ME, Hicks DJ, et al: KiSS-1,
a novel human malignant melanoma metastasis-suppressor gene. J Natl
Cancer Inst. 88:1731–1737. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Makri A, Pissimissis N, Lembessis P, et
al: The kisspeptin (KISS-1)/GPR54 system in cancer biology. Cancer
Treat Rev. 34:682–692. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Masui T, Doi R, Mori T, et al: Metastin
and its variant forms suppress migration of pancreatic cancer
cells. Biochem Biophys Res Commun. 315:85–92. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Martin TA, Watkins G and Jiang WG: KiSS-1
expression in human breast cancer. Clin Exp Metastasis. 22:503–511.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Nicolle G, Comperat E, Nicolaïew N, et al:
Metastin (KISS-1) and metastin-coupled receptor (GPR54) expression
in transitional cell carcinoma of the bladder. Ann Oncol.
18:605–606. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Zohrabian VM, Nandu H, Gulati N, et al:
Gene expression profiling of metastatic brain cancer. Oncol Rep.
18:321–328. 2007.PubMed/NCBI
|
|
13.
|
Hata K, Dhar DK, Watanabe Y, et al:
Expression of metastin and a G-protein-coupled receptor (AXOR12) in
epithelial ovarian cancer. Eur J Cancer. 43:1452–1459. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Yamashita S, Tsujino Y, Moriguchi K, et
al: Chemical genomic screening for methylation-silenced genes in
gastric cancer cell lines using 5-aza-2′-deoxycytidine treatment
and oligonucleotide microarray. Cancer Sci. 97:64–71.
2006.PubMed/NCBI
|
|
15.
|
Seminara SB, Messager S, Chatzidaki EE, et
al: The GPR54 gene as a regulator of puberty. N Engl J Med.
349:1614–1627. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
De Roux N, Genin E, Carel JC, et al:
Hypogonadotropic hypogonadism due to loss of function of the
KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A.
100:10972–10976. 2003.
|
|
17.
|
Ohtaki T, Shintani Y, Honda S, et al:
Metastasis suppressor gene KiSS-1 encodes peptide ligand of a
G-protein-coupled receptor. Nature. 411:613–617. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Stafford LJ, Xia C, Ma W, et al:
Identification and characterization of mouse metastasis-suppressor
KiSS1 and its G-protein coupled receptor. Cancer Res. 62:5399–5404.
2002.PubMed/NCBI
|
|
19.
|
Mitchell DC, Stafford LJ, Li D, et al:
Transcriptional regulation of KiSS-1 gene expression in metastatic
melanoma by specificity protein-1 and its coactivator DRIP-130.
Oncogene. 26:1739–1747. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Mead EJ, Maguire JJ, Kuc RE, et al:
Kisspeptins: a multifunctional peptide system with a role in
reproduction, cancer and the cardiovascular system. Br J Pharmacol.
151:1143–1153. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Ikeguchi M, Hirooka Y and Kaibara N:
Quantitative reverse transcriptase polymerase chain reaction
analysis for KiSS-1 and orphan G-protein-coupled receptor
(hOT7T175) gene expression in hepatocellular carcinoma. J Cancer
Res Clin Oncol. 129:531–535. 2003. View Article : Google Scholar
|
|
22.
|
Zhang SL, Yu Y, Jiang T, et al: Expression
and significance of KiSS-1 and its receptor GPR54 mRNA in
epithelial ovarian cancer. Zhonghua Fu Chan Ke Za Zhi. 40:689–692.
2005.(In Chinese).
|
|
23.
|
Tanoue LT and Detterbeck FC: New TNM
classification for non-small-cell lung cancer. Expert Rev
Anticancer Ther. 9:413–423. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Katagiri F, Tomita K, Oishi S, et al:
Establishment and clinical application of enzyme immunoassays for
determination of luteinizing hormone releasing hormone and
metastin. J Pept Sci. 13:422–429. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Lee JH and Welch DR: Identification of
highly expressed genes in metastasis-suppressed chromosome 6/human
malignant melanoma hybrid cells using subtractive hybridization and
differential display. Int J Cancer. 71:1035–1044. 1997. View Article : Google Scholar
|
|
26.
|
Ikeguchi M, Yamaguchi K and Kaibara N:
Clinical significance of the loss of KiSS-1 and orphan
G-protein-coupled receptor (hOT7T175) gene expression in esophageal
squamous cell carcinoma. Clin Cancer Res. 10:1379–1383. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Dhar DK, Naora H, Kubota H, et al:
Downregulation of KiSS-1 expression is responsible for tumor
invasion and worse prognosis in gastric carcinoma. Int J Cancer.
111:868–872. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Schmid K, Wang X, Haitel A, et al: KiSS-1
overexpression as an independent prognostic marker in
hepatocellular carcinoma: an immunohistochemical study. Virchows
Arch. 450:143–149. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Zheng S, Chang Y, Hodges KB, et al:
Expression of KISS1 and MMP-9 in non-small cell lung cancer and
their relations to metastasis and survival. Anticancer Res.
30:713–718. 2010.PubMed/NCBI
|
|
30.
|
Karapanagiotou EM, Dilana KD, Gkiozos I,
et al: Metastin is not involved in metastatic potential of
non-small cell lung cancer. Med Oncol. 28:559–564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Cebrian V, Fierro M, Orenes-Piñero E, et
al: KISS1 methylation and expression as tumor stratification
biomarkers and clinical outcome prognosticators for bladder cancer
patients. Am J Pathol. 179:540–546. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Moya P, Esteban S, Fernandez-Suarez A, et
al: KiSS-1 methylation and protein expression patterns contribute
to diagnostic and prognostic assessments in tissue specimens for
colorectal cancer. Tumour Biol. 34:471–479. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Muir AI, Chamberlain L, Elshourbagy NA, et
al: AXOR12, a novel human G protein-coupled receptor, activated by
the peptide KiSS-1. J Biol Chem. 276:28969–28975. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Kotani M, Detheux M, Vandenbogaerde A, et
al: The metastasis suppressor gene KiSS-1 encodes kisspeptins, the
natural ligands of the orphan G protein-coupled receptor GPR54. J
Biol Chem. 276:34631–34636. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Jarząbek K, Kozłowski L, Milewski R, et
al: KiSS1/GPR54 and estrogen-related gene expression profiles in
primary breast cancer. Oncol Lett. 3:930–934. 2012.PubMed/NCBI
|
|
36.
|
Zajac M, Law J, Cvetkovic DD, et al: GPR54
(KISS1R) transactivates EGFR to promote breast cancer cell
invasiveness. PLoS One. 6:e215992011. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Niida A, Wang Z, Tomita K, et al: Design
and synthesis of downsized metastin (45–54) analogs with
maintenance of high GPR54 agonistic activity. Bioorg Med Chem Lett.
16:134–137. 2006.PubMed/NCBI
|
|
38.
|
Horikoshi Y, Matsumoto H, Takatsu Y, et
al: Dramatic elevation of plasma metastin concentrations in human
pregnancy: metastin as a novel placentaderived hormone in humans. J
Clin Endocrinol Metab. 88:914–919. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Katagiri F, Nagai K, Kida A, et al:
Clinical significance of plasma metastin level in pancreatic cancer
patients. Oncol Rep. 21:815–819. 2009.PubMed/NCBI
|
